Statement from Aaron J. Kowalski, Ph.D., President and CEO of JDRF, on New...
NEW YORK, February 18, 2020 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, issued this statement based on two new reports issued by the Centers for Disease Control and...
View ArticleJDRF Names New Board Chair, Vice Chair
NEW YORK, February 20, 2020 – JDRF, a global leader in type 1 diabetes (T1D) research, today announced the appointment of two long-time volunteers to lead its International Board of Directors (IBOD)....
View ArticleCongressional Relief Package Extends Special Diabetes Program and Provides...
Funding for community health centers and extended prescription drug refills among the benefits for people with type 1 diabetes.read more
View ArticleZucara Therapeutics Announces US$21 Million Series A Financing
Toronto, Canada, March 31, 2020 – Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose...
View ArticleJDRF Statement on Lilly $35 Co-pay Card for Insulin in Response to COVID-19...
At JDRF, we welcome Lilly’s decision to introduce a co-pay card that allows anyone using commercial insurance, as well as those without any insurance, to purchase their monthly prescription of Lilly...
View ArticleJDRF Partners with Ragnar to Launch Virtual Events Supporting the T1D Community
NEW YORK, [April 15, 2020] – JDRF, the global leader in type 1 diabetes (T1D) research, today announced it will be the official charity partner of Ragnar, the largest running relay series in the world,...
View ArticleThe JDRF Beyond Type 1 Alliance Releases Recommendations for People with...
The recommendations are supported by 50 international organizations working together to curb the spread of COVID-19 and protect those most vulnerable. read more
View ArticleStem Cell Initiative Submits Signatures to Qualify for November Ballot
Overcoming Challenges from COVID-19, the Campaign Activated Patient Advocacy Groups to Collect Signatures by Mail to Cross the Finish Line While Voters ‘Sheltered in Place’read more
View ArticleInsulins Available at U.S. Pharmacies are Consistent with Product Labeling,...
The study examined the potency and consistency of active insulin in products available across the United States.read more
View ArticleJDRF Statement on NHS Englands COVID-19 Study
The study, which examines patients within the U.K. hospital system, showed an increased risk of fatality in individuals with T1D hospitalized with the coronavirus compared to type 2 diabetes and the...
View ArticleNew Research from the Indiana Biosciences Research Institute Identifies Two...
JDRF sponsors research that finds interferon-α promotes rapid changes in chromatin, triggering autoimmunity and type 1 diabetes.read more
View ArticleJDRF and Ragnar Announce the 200 for T1D Virtual Relay Challenge
New York, June 9, 2020 – JDRF, the global leader in type 1 diabetes (T1D) research, and Ragnar, the largest overnight running relay series in the United States, announced the “200 for T1D” Virtual...
View ArticleNew Findings from Groundbreaking Study Shows Extended Delay in Onset of Type...
NEW YORK – June 15, 2020— Emily Sims, M.D. today shared new findings that a breakthrough drug significantly delays the onset of type 1 diabetes (T1D).read more
View ArticleGame Over, T1D! Type 1 Diabetes Nonprofit JDRF Kicks Off Virtual Fundraising...
NEW YORK – June 26, 2020 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, will hold a 12-hour charity fundraiser on Twitch this Saturday, June 27 th to bring together...
View ArticleJDRF Celebrates UnitedHealthcares Expanded Insulin Pump Coverage
In a victory for JDRF’s Coverage2Control Campaign , people with T1D now will have more choice in how they manage their diabetes read more
View ArticleJDRF & Lokai Enter Second Year Of Partnership To Continue Bringing Balance To...
The Diabetes Lokai bracelet provides wearers with a daily reminder to find balance through life’s highs and lows. read more
View ArticleJDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D...
San Diego, CA – July 8, 2020 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical device company dedicated to improving the...
View ArticleGame Over, T1D! JDRFs 10-Day Livestream Fundraiser for Type 1 Diabetes...
NEW YORK – August 6, 2020 – Online livestream fundraisers are the telethons of the twenty-first century and JDRF, the leading global organization funding type 1 diabetes (T1D) research, is kicking off...
View ArticleNew test better predicts which babies will develop type 1 diabetes
A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.read more
View ArticleJDRF Celebrates Hispanic Heritage Month
New York, September 15, 2020 — JDRF, the leading global funder of type 1 diabetes (T1D) research, is excited to announce new bilingual resources and multicultural initiatives launching during Hispanic...
View ArticleJDRF Re-Imagines the TypeOneNation Summit into Virtual National Event
New York, September 21, 2020— JDRF, the leading global funder of type 1 diabetes (T1D) research, announces the newly reimagined TypeOneNation Summit.read more
View ArticleJDRF Celebrates the Progress, Resilience and Diversity of the T1D Community...
September 28, 2020, New York—On Saturday, September 26, JDRF, the leading global funder of type 1 diabetes (T1D) research, hosted its first-ever National TypeOneNation Virtual Summit.read more
View ArticleJDRF Supported Researchers Showcased at the 56th European Association for the...
New York, October 5, 2020 —JDRF supported researchers showcased advances in type 1 diabetes (T1D) research shared at this year’s 56 th European Association for the Study of Diabetes (EASD) Annual...
View ArticleJDRF One Walk Goes Virtual
New York, October 12 , 2020 —JDRF, the leading global funder of type 1 diabetes (T1D) research, announces the annual community-based fundraiser One Walk’s reimagination into one, nationwide event...
View ArticleJDRF and SCOTTeVEST Partner in Support of the Type 1 Diabetes (T1D) Community
New York and Ketchum, ID, October 20, 2020 —JDRF, the global leader in type 1 diabetes (T1D) research, announces a new partnership with SCOTTeVEST (SeV), a clothing brand known for multi-pocket,...
View ArticleJDRF Celebrates the Strength of the Type 1 Diabetes Community with the Power...
NEW YORK—October 28, 2020— JDRF, the leading global funder of type 1 diabetes (T1D) research, commemorates National Diabetes Awareness Month (NDAM) by honoring the strength of the T1D community with...
View Article$14 Million Push for Type 1 Diabetes Breakthroughs: New JDRF Center of...
NEW YORK, NY and ANN ARBOR, MI – Michigan Medicine, through its Elizabeth Weiser Caswell Diabetes Institute (EWCDI), and JDRF are collaborating to establish the JDRF Center of Excellence at the...
View ArticleAnthem Foundation and JDRF Partner to Address Mental Health Needs During...
New York, December 3, 2020 — Approximately 1 in 5 Americans experience a mental health condition, and the current COVID-19 pandemic has increased demand for mental health services. JDRF, the leading...
View ArticleJDRF Named Winner of 2020 Amazon Web Services Imagine Grant for Nonprofits
JDRF will work with Amazon’s cloud computing arm to leverage technology to support the T1D community.read more
View ArticleJDRF Announces New Center of Excellence in New England to Advance Type 1...
The multi-institutional center will focus on accelerating gene editing approaches for beta cell replacement therapy.read more
View ArticleJDRF, Lupus Research Alliance and National Multiple Sclerosis Society Join...
NEW YORK, NY, February 24, 2021 – JDRF International, the Lupus Research Alliance and the National Multiple Sclerosis Society joined forces to accelerate research and discovery in autoimmunity and are...
View ArticleJDRF Celebrates the Strength of the T1D Community at the TypeOneNation...
April 27, 2021, New York —On Saturday, April 24, 2021, JDRF, the leading global funder of type 1 diabetes (T1D) research, celebrated the strength of the community with its second virtual TypeOneNation...
View ArticleJDRF Chair Premier Panel at 2021 Advanced Technologies & Treatments for...
June 2, 2021, New York— JDRF, the leading global funder of type 1 diabetes (T1D) research, is set to host a panel and live Q&A session at the 14 th International Conference on Advanced Technologies...
View ArticleJDRF Official Statement on the Launch of Walmarts Low-Cost Insulin Brand
JDRF welcomes Walmart’s announcement regarding their plan to offer lower-cost insulin. Walmart, working directly with Novo Nordisk, will launch ReliOn Novolog in both vials and FlexPens. The vial will...
View ArticleJDRF and the Association of Diabetes Care & Education Specialists Announce...
New York, July 20, 2021— JDRF, the leading global funder of Type 1 diabetes research, and the Association of Diabetes Care & Education Specialists, the largest organization dedicated to diabetes...
View ArticleJDRF x Beyond Type 1 Alliance Offers Type 1 Diabetes Community First-Ever...
New York, July 22, 2021— JDRF and Beyond Type 1 present the TypeOneNation Summit: Viviendo sin Límites, the first national Spanish-language type 1 diabetes (T1D) community symposium.read more
View ArticleJDRF Mourns the Loss of Professor David Dunger
JDRF mourns the loss of renowned researcher Professor David Dunger, FMedSci, a pioneer in type 1 diabetes (T1D) research and a trusted JDRF investigator, partner, reviewer, and collaborator. read more
View ArticleJDRF Announces the Appointment of Dr. Shereef Elnahal to the JDRF Research...
New York, August 18, 2021 —JDRF, the leading global funder of type 1 diabetes (T1D) research, proudly announces the appointment of Dr. Shereef Elnahal to the JDRF Research Committee.read more
View ArticleNational Diabetes Coalition Provides Support for The Diabetes Community In...
ARLINGTON, Va. (September 9, 2021) – In the wake of continued widespread flooding and power outages in the US Gulf Coast and Northeast from Hurricane Ida, the Diabetes Disaster Response Coalition...
View ArticleRaise Awards Honors Nonprofits Shaping the Future of Fundraising
September 14, 2021 — INDIANAPOLIS and NEW YORK – OneCause , a leader in online and event fundraising, recognized fundraising innovation and excellence at its annual Raise Awards ceremony during the...
View ArticleJDRF Announces the Addition of Shia Learns About Insulin book into the Bag of...
New York, September 15, 2021— JDRF, the leading global funder of type 1 diabetes research, today proudly announces the inclusion of the book Shia Learns About Insulin into the Bag of Hope.read more
View ArticleJDRF Awards New Grant to Explore Cognitive Behavioral Therapy to Reduce...
New York, NY, September 30, 2021— JDRF, the leading global nonprofit funder of type 1 diabetes (T1D) research, announces a new grant awarded to Albert Einstein College of Medicine and Montefiore Health...
View ArticlevTv Therapeutics Announces Positive Results from Mechanistic Study Indicating...
Patients taking TTP399 reported no events of hypoglycemia, while four events of hypoglycemia were reported in the placebo armread more
View ArticleJDRF Honors Champions of the Type 1 Diabetes Community for National Diabetes...
NEW YORK—November 1, 2021— JDRF , the leading global funder of type 1 diabetes (T1D) research, celebrates National Diabetes Awareness Month (NDAM) by honoring changemakers in the T1D community with the...
View ArticleJDRF International voices disappointment as drug for type 1 diabetes is...
The leading global type 1 diabetes charity, JDRF international, expresses its disappointment with the removal of a drug from the UK and European marketplace that can help people living with type 1...
View ArticleThe Rap Game Star Nia Kay Releases New Single Go Best Friend And Named...
New York, NY – (November 18th, 2021) – Chicago rapper and rising star, Nia Kay is set to release a new single titled, “ Go Best Friend ” on Friday, November 19. Nia releases this new single on the...
View ArticleJDRF Announces the Relaunch of Rufus, the Bear with Diabetes
New York, December 1, 2021 — JDRF, the leading global funder of type 1 diabetes (T1D) research, proudly announces the relaunch of Rufus, the Bear with Diabetes®.read more
View ArticleJDRF International Announces the First Canadian Centre of Excellence in Type...
Toronto, ON and New York, NY — December 8, 2021 – JDRF Canada, the largest Canadian charitable funder of type 1 diabetes (T1D) research, and the UBC Faculty of Medicine are proud to announce the...
View ArticleJDRF and Ford Announces Winner of 2021 Bronco First Edition Four-Door in...
New York, NY and Dearborn, MI, December 16, 2021 — JDRF, in collaboration with Ford Motor Company, together announce the fundraising sweepstakes winner of the 2021 Bronco First Edition, Derek B. of...
View ArticleRapper and Actress Nia Kay Releases New Go Best Friend Video Aimed To Spread...
New York, NY – January 20, 2022 – Chicago rapper and rising star, Nia Kay is set to release her new music video titled, “Go Best Friend” on Friday, January 21, following an exclusive premiere today...
View Article